PDL BioPharma, Inc. Operating Expenses
PDL BioPharma, Inc. reported Operating Expenses of $82.03 million for the 12-month period ending 2019-12-31, per its 8-K filed 2020-06-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2020-06-29
- PDL BioPharma, Inc. operating expenses for the quarter ending 2019-12-31 was -$8.52M.
- PDL BioPharma, Inc. operating expenses for the quarter ending 2019-09-30 was $34.72M, a 11.44% increase year-over-year.
- PDL BioPharma, Inc. operating expenses for the quarter ending 2019-06-30 was $27.39M, a 84.05% decline year-over-year.
- PDL BioPharma, Inc. operating expenses for the quarter ending 2019-03-31 was $28.44M, a 16.90% decline year-over-year.
- PDL BioPharma, Inc. operating expenses for fiscal 2016 was $114.90M, a 186.75% increase from fiscal 2015.
- PDL BioPharma, Inc. operating expenses for fiscal 2015 was $40.07M, a 14.76% increase from fiscal 2014.
- PDL BioPharma, Inc. operating expenses for fiscal 2014 was $34.91M, a 17.34% increase from fiscal 2013.
- PDL BioPharma, Inc. operating expenses for fiscal 2013 was $29.75M, a 16.83% increase from fiscal 2012.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|
| 2019-12-31 | -$8.52M derived: 8-K 12 month − 10-Q 9 month · filed 2020-06-29 | $26.20M derived: sum of 2 quarters · filed 2020-06-29 | $53.59M derived: sum of 3 quarters · filed 2020-06-29 | $82.03M 8-K · filed 2020-06-29 | $154.57M 10-K · filed 2020-03-11 |
| 2019-09-30 | $34.72M 10-Q · filed 2019-11-06 | $62.11M derived: sum of 2 quarters · filed 2019-11-06 | $90.55M 10-Q · filed 2019-11-06 | -$80.31M derived: sum of 4 quarters · filed 2020-06-29 | |
| 2019-06-30 | $27.39M 10-Q · filed 2019-08-07 | $55.83M 10-Q · filed 2019-08-07 | -$115.03M derived: sum of 3 quarters · filed 2020-06-29 | -$83.88M derived: sum of 4 quarters · filed 2020-06-29 | |
| 2019-03-31 | $28.44M 10-Q · filed 2019-05-09 | -$142.42M derived: sum of 2 quarters · filed 2020-06-29 | -$111.27M derived: sum of 3 quarters · filed 2020-06-29 | $60.44M derived: sum of 4 quarters · filed 2020-06-29 | |
| 2018-12-31 | -$170.87M derived: 8-K 12 month − 10-Q 9 month · filed 2020-06-29 | -$139.71M derived: sum of 2 quarters · filed 2020-06-29 | $31.99M derived: sum of 3 quarters · filed 2020-06-29 | $66.22M 8-K · filed 2020-06-29 | $248.70M 10-K · filed 2019-03-15 |
| 2018-09-30 | $31.16M 10-Q · filed 2019-11-06 | $202.86M derived: sum of 2 quarters · filed 2019-11-06 | $237.08M 10-Q · filed 2019-11-06 | $202.26M derived: sum of 4 quarters · filed 2020-06-29 | |
| 2018-06-30 | $171.70M 10-Q · filed 2019-08-07 | $205.93M 10-Q · filed 2019-08-07 | $171.10M derived: sum of 3 quarters · filed 2020-06-29 | $201.23M derived: sum of 4 quarters · filed 2020-06-29 | |
| 2018-03-31 | $34.23M 10-Q · filed 2019-05-09 | -$602.00K derived: sum of 2 quarters · filed 2020-06-29 | $29.53M derived: sum of 3 quarters · filed 2020-06-29 | $60.58M derived: sum of 4 quarters · filed 2020-06-29 | |
| 2017-12-31 | -$34.83M derived: 8-K 12 month − 10-Q 9 month · filed 2020-06-29 | -$4.70M derived: sum of 2 quarters · filed 2020-06-29 | $26.36M derived: sum of 3 quarters · filed 2020-06-29 | $53.29M 8-K · filed 2020-06-29 | $126.28M 10-K · filed 2018-03-16 |
| 2017-09-30 | $30.13M 10-Q · filed 2018-11-07 | $61.18M derived: sum of 2 quarters · filed 2018-11-07 | $88.12M 10-Q · filed 2018-11-07 | $162.28M derived: sum of 4 quarters · filed 2019-03-15 | |
| 2017-06-30 | $31.05M 10-Q · filed 2018-08-09 | $57.99M 10-Q · filed 2018-08-09 | $132.15M derived: sum of 3 quarters · filed 2019-03-15 | $153.13M derived: sum of 4 quarters · filed 2019-03-15 | |
| 2017-03-31 | $26.93M 10-Q · filed 2018-05-09 | $101.09M derived: sum of 2 quarters · filed 2019-03-15 | $122.08M derived: sum of 3 quarters · filed 2019-03-15 | $131.99M derived: sum of 4 quarters · filed 2019-03-15 | |
| 2016-12-31 | $74.16M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $95.14M derived: sum of 2 quarters · filed 2019-03-15 | $105.05M derived: sum of 3 quarters · filed 2019-03-15 | $114.90M 10-K · filed 2019-03-15 | |
| 2016-09-30 | $20.98M 10-Q · filed 2017-11-13 | $30.89M derived: sum of 2 quarters · filed 2017-11-13 | $40.74M 10-Q · filed 2017-11-13 | $57.26M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-06-30 | $9.91M 10-Q · filed 2017-08-03 | $19.76M 10-Q · filed 2017-08-03 | $36.28M derived: sum of 3 quarters · filed 2018-03-16 | $44.73M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-03-31 | $9.85M 10-Q · filed 2017-05-03 | $26.37M derived: sum of 2 quarters · filed 2018-03-16 | $34.82M derived: sum of 3 quarters · filed 2018-03-16 | $42.25M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2015-12-31 | $16.52M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $24.97M derived: sum of 2 quarters · filed 2018-03-16 | $32.40M derived: sum of 3 quarters · filed 2018-03-16 | $40.07M 10-K · filed 2018-03-16 | |
| 2015-09-30 | $8.45M 10-Q · filed 2016-11-03 | $15.88M derived: sum of 2 quarters · filed 2016-11-03 | $23.55M 10-Q · filed 2016-11-03 | ||
| 2015-06-30 | $7.43M 10-Q · filed 2016-08-04 | $15.10M 10-Q · filed 2016-08-04 | |||
| 2014-12-31 | $34.91M 10-K · filed 2017-03-01 | ||||
| 2014-03-31 | $16.51M 10-Q · filed 2014-05-12 | ||||
| 2013-12-31 | $29.75M 10-K · filed 2016-02-23 | $35.39M 10-K · filed 2014-03-03 | |||
| 2013-03-31 | $7.19M 10-Q · filed 2014-05-12 | ||||
| 2012-12-31 | $25.47M 10-K · filed 2014-03-03 | ||||
| 2011-12-31 | $18.34M 10-K · filed 2014-03-03 | ||||
| 2010-12-31 | $133.90M 10-K · filed 2013-03-01 | ||||
| 2009-12-31 | $21.06M 10-K · filed 2012-02-23 | ||||
| 2008-12-31 | $51.54M 10-K · filed 2011-03-01 |